Literature DB >> 24880233

A case of cerebellar hemangioblastoma with rhabdoid features.

Ayako Tomono1, Shigeo Hara, Takanori Hirose, Tomoo Itoh.   

Abstract

We present an unusual case of cerebellar hemangioblastoma characterized by rhabdoid features. The patient was a 35-year-old Japanese man with occipital neuralgia and exacerbating blurred vision. Magnetic resonance imaging revealed a left posterior cranial fossa tumor, which was isointense on T1-weighted images and hyperintense on T2-weighted images with marked homogeneous enhancement. Histology of the surgically resected tumor showed cellular-type hemangioblastoma with extensive proliferation of rhabdoid cells Immunohistochemistry analysis showed tumor cells positive for inhibin A, CD56, vimentin, INI-1, and vascular endothelial growth factor; negative for PAX8, CD10, epithelial membrane antigen, cytokeratin, (AE1/3), alpha-smooth muscle actin and D2-40; and had focal positivity for glial fibrillary acidic protein and S100. The Ki-67 labeling index was <1 %. Ultrastructural analysis revealed large lipid droplets and abundant intracellular accumulation of intermediate filaments. Based on these findings, the diagnosis was hemangioblastoma with focal rhabdoid features. After a 14-month follow-up, there was no evidence of recurrence. This is the first report of hemangioblastoma with rhabdoid features in the central nervous system. In addition, we discuss the possible pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24880233     DOI: 10.1007/s10014-014-0193-1

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  1 in total

1.  Short-Spindled Cell Haemangioblastoma with CD34 Expression: New Histopathological Variant or Just a Stochastic Cytological Singularity?

Authors:  Miguel Fdo Salazar; Paola Andrea Escalante Abril; María Verónica Velasco Vales; Celene Martínez Ruiz; Erick Gómez Apo; Laura G Chávez Macías
Journal:  Case Rep Pathol       Date:  2016-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.